Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate 
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment 
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine 
Ford and Geely Explore Strategic Manufacturing Partnership in Europe 
Australian Scandium Project Backed by Richard Friedland Poised to Support U.S. Critical Minerals Stockpile 
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch 
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies 
Boeing Signals Progress on Delayed 777X Program With Planned April First Flight 
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million 
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026 
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering 
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks 
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge 
CK Hutchison Unit Launches Arbitration Against Panama Over Port Concessions Ruling 
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links 
Nintendo Shares Slide After Earnings Miss Raises Switch 2 Margin Concerns 
AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock 
Albany, NY, Feb. 03, 2016 -- Driven by the increased sales of medicinal drugs globally, the pharmacovigilance industry will find several opportunities for growth in the coming years, finds a latest report that is now available on MarketResearchReports.biz. The report, titled ‘Global Pharmacovigilance Industry 2015 Market Research Report’, whittles the global market into multiple segments and sub-segments to create a rich and comprehensive analysis.
The findings of the report suggest that thanks to a rise in the number of adverse drug reactions reported across the world, the deployment of pharmacovigilance methods will show a parallel rise. The report, prepared by seasoned industry experts, relies extensively on both primary and secondary research in order to analyze the current dynamics of the global pharmacovigilance industry. This report also identifies key trends that will augur well for the growth of the global pharmacovigilance industry, with outsourcing of pharmacovigilance activities being identified as a major trend.
However, given the sensitive nature of pharmacovigilance, breach of confidential data repositories is a risk that companies in the market need to actively alleviate. For this purpose, joint collaborations might be the way ahead. Collaborations between private players such as life sciences companies and pharmaceutical manufacturers as well as public entities such as regulatory authorities could be seen in the coming years within the pharmacovigilance market. The other restraint that the market for pharmacovigilance is likely to face is a dearth of skilled professionals.
View Press Release at: http://www.marketresearchreports.biz/pressrelease/360
The report on the pharmacovigilance industry begins with a general overview of the industry, where clients can acquaint themselves with basics such as definition and classification of pharmacovigilance. This chapter also discusses the applications of various pharmacovigilance methods and the characteristics of pharmacovigilance. Moving further, the report discusses the barriers to entry that currently exist in this market.
In the subsequent chapters, the report delves on the state of the pharmacovigilance industry in the international context and specifically in China. The competitive landscape is analyzed in detail as part of the analysis of this report, for both global and China markets. The most important development trends are discussed in detail so as to provide industry stakeholders a complete picture of the opportunities that lie within these trends.
Since current policies and new developments have a bearing on the growth trajectory of the global pharmacovigilance industry, understanding them becomes a winning imperative. This is precisely what the report offers. Details of the current and projected revenue of the market as a whole and that of individual segments studied within the pharmacovigilance industry are presented. Revenues of important national markets such as the U.S., China, and Japan are projected separately. The revenue expected to be generated by the pharmacovigilance industry in Europe is also projected in the report.
The leading players that are profiled in the global pharmacovigilance industry report are Oracle, ArisGlobal, Sparta Systems, Extedo, UBC, Sarjen, Ennov, and others.
Related Reports:
Global Pharmaceutical Packaging Market 2016-2020: http://www.marketresearchreports.biz/analysis/502500
US Nuclear Medicine/Radiopharmaceuticals Industry 2015 Market Research Report: http://www.marketresearchreports.biz/analysis/482629
About MarketResearchReports.biz
Marketresearchreports.biz is the most comprehensive collection of market research reports, supporting clients' market intelligence needs with over 100,000 market research reports, company profiles, data books, and regional market profits in its repository. We also offer consulting support for custom market research needs.
MarketResearchReports.biz Mr. Nachiket Ghumare, +1-518-621-2074 USA-Canada Toll Free: 866-997-4948 [email protected] http://www.marketresearchreports.biz/
